Synovus Financial Corp Verastem, Inc. Transaction History

Synovus Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$0.33 - $10.44 $13,005 - $411,450	39,411 Added 53.99%	112,411 $44,000
Q2 2022 Aug 10, 2022	SELL	$1.02 - $1.83 $35,700 - $64,050	-35,000 Reduced 32.41%	73,000 $85,000
Q1 2022 May 12, 2022	BUY	$1.06 - $2.1 $10,600 - $21,000	10,000 Added 10.2%	108,000 $152,000
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $180,399 - $281,600	88,000 Added 880.0%	98,000 $201,000
Q3 2021 Nov 08, 2021	BUY	$2.54 - $4.07 $25,400 - $40,700	10,000 New	10,000 $31,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.